DCS Innovative Diagnostik Systeme   Report issue

For profit Phase 3
Founded: Hamburg Germany (2000)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2008
NCT00779714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5